<SEC-DOCUMENT>0001437749-23-008873-index.html : 20230331
<SEC-HEADER>0001437749-23-008873.hdr.sgml : 20230331
<ACCEPTANCE-DATETIME>20230331171316
ACCESSION NUMBER:		0001437749-23-008873
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		5
REFERENCES 429:			333-218469
REFERENCES 429:			333-222625
REFERENCES 429:			333-236328
REFERENCES 429:			333-252155
REFERENCES 429:			333-264953
FILED AS OF DATE:		20230331
DATE AS OF CHANGE:		20230331
EFFECTIVENESS DATE:		20230331

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NovaBay Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001389545
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				680454536
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-271053
		FILM NUMBER:		23789114

	BUSINESS ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		(510) 899-8800

	MAIL ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>nby20230328_s8.htm
<DESCRIPTION>FORM S-8
<TEXT>
Document 1 - file: nby20230328_s8.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ex_494384.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
Document 2 - file: ex_494384.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ex_495178.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
Document 3 - file: ex_495178.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>ex_494385.htm
<DESCRIPTION>EXHIBIT FILING FEES
<TEXT>
Document 4 - file: ex_494385.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>spblogo.jpg
<TEXT>
Document 5 - file: spblogo.jpg

</DOCUMENT>
</SEC-DOCUMENT>